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mass expansion. The average iron requirement due to by lactation (0.33 mg/d) was calculated from the average iron concentration (0.426 mg/L) (10) and volume of secretion (0.78 L/d) (11, 12) of breast milk in Japanese women.
In accordance with a value adopted by the World Health Organization (WHO) and the Food and Agricultural Organization (FAO) (13) , the average percentage of dietary iron absorption by all ages is estimated to be 15% except for women during the mid and late stages of pregnancy, for whom it is estimated to be 25% (14) . The EARs were calculated as follows: men and non-menstruating women aged 18 y and older, EAR5basal loss/ absorption; menstruating women aged 18 y and older, EAR5(basal loss1menstrual loss)/absorption; boys and non-menstruating girls aged 6 mo to 17 y, EAR5(basal loss1accumulation with growth)/absorption; menstruating girls aged 10 to 17 y, EAR5(basal loss1menstrual loss1accumulation with growth)/absorption; pregnant and lactating women, additional EAR5increased demand induced by pregnancy or lactation/absorption. The recommended dietary allowances (RDAs) were determined as follows: children aged 6 mo to 14 y, EAR31.4; aged 15 or older, EAR31.2.
The adequate intake (AI) for infants aged 0 to 5 mo was calculated based on mean iron intake of infants fed breast milk as follows: AI5average iron concentration in breast milk in Japanese women (0.426 mg/L) (10)3average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) . The tolerable upper intake levels (ULs) for individuals aged 15 y or older was set at 0.8 mg/kg/d according to the provisional maximal tolerable intake reported by the WHO and FAO (15) . The UL for toddlers aged 1 to 2 y was set at 2.0 mg/kg/d based on the lowest observed adverse effect level (LOAEL) for toddlers, which is 60 mg/kg/d (16) , and an uncertainty factor of 30. The ULs for children aged 3 to 5 y, 6 to 7 y, 8 to 9 y, and 10 to 14 y were set at 1.6, 1.4, 1.2, and 1.0 mg/kg/d, respectively. Table 1 summarizes the DRIs for iron. The EARs and RDAs in this table do not apply to women with hypermenorrhea, defined as menstrual blood loss over 80 mL per month.
Zinc

Background information
Zinc is an essential component of almost 100 specific enzymes, including alcohol dehydrogenase and RNA polymerases. Zinc deficiency may occur in patients receiving prolonged total parenteral nutrition (TPN) without zinc supplementation (17) or in infants fed breast milk with low zinc content (18) , and manifests as several specific symptoms, including acrodermatitis enteropathica, hypogeusia, and chronic diarrhea. 1 The values were set excluding those with menorrhagia (blood loss exceeding 80 mL/period).
Determining DRIs
The EAR for zinc was determined using a factorial modeling method in which the factors were urinary zinc excretion, the sum of integumental and sweat zinc loss, zinc loss in semen or menstrual blood, endogenous zinc excretion via the intestine, and the extent of absorption of dietary zinc. The RDA for zinc was set equal to 120% of the EAR. As estimated according to the US/Canadian DRIs (19) , urinary zinc excretion, the sum of integumental and sweat zinc loss, and zinc loss in semen or menstrual blood for adults of a reference body weight (men, 76 kg; women, 61 kg) were found to be the following: urinary zinc loss, 0.63 (men) and 0.44 mg/d (women); sum of integumental and sweat zinc loss, 0.54 (men) and 0.46 mg/d (women); zinc loss in semen, 0.10 mg/d; and zinc losses in menstrual blood, 0.10 mg/d. As a result, endogenous zinc losses via routes other than the intestine for men and women were determined to be 1.27 (0.6310.5410.10) mg/d and 1.00 (0.4410.4610.10) mg/d, respectively.
The results of several studies using a stable isotope (20) (21) (22) (23) (24) (25) (26) have shown that the relationship between endogenous zinc excretion via the intestine and the quantity of zinc absorbed in adults with a body weight of 76 kg can be calculated using the following equation: endogenous excretion via the intestine50.6283(quantity absorbed10.2784). Because total endogenous zinc excretion is the sum of endogenous excretion via the intestine and other routes, the relationship between total endogenous zinc excretion and quantity of zinc absorbed in adults with a body weight of 76 kg can be calculated using the following equations: men, total endogenous excretion50.6283(quantity absorbed10.278411.27); women, total endogenous excretion50.6283(quantity ). The quantity of zinc intake necessary to achieve zinc balance, the state in which zinc absorption is equal to total endogenous excretion, has been calculated to be 4.16 mg/d for men and 3.92 mg/d for women. The relationship between zinc absorption and zinc intake is expressed by the following equation (20) (21) (22) (23) (24) (25) (26) : quantity of absorbed zinc 51.1133(zinc intake) 0.5462 . The EAR for zinc, defined as the minimal intake necessary to maintain zinc balance, for adults with a body weight of 76 kg was determined to be 11.18 mg/d for men and 10.03 mg/d for women. These values were extrapolated to the EAR for each age group of adults aged 18 y or older using the 0.75th power of a weight ratio. The EAR for adolescents aged 12 to 17 y was determined by extrapolation of the EAR for adults using the 0.75th power of a weight ratio and a growth factor.
In a study of Japanese children (mean body weight, 16.34 kg), the minimal intake necessary to maintain zinc balance was estimated to be 3.87 mg/d (27) . Thus, the EAR for children with a body weight of 16.34 kg was calculated to be 4.06 mg/d, which is obtained by addition of 3.87 mg/d to the sum of integumental and sweat zinc loss (0.19 mg/d). The EAR for children aged 1 to 11 y was determined by extrapolation of 4.06 mg/d to each age group using the 0.75th power of a weight ratio and a growth factor. The additional EAR for pregnant women, which was determined by measurement of zinc storage during pregnancy (0.40 mg/d) (28) and extent of zinc absorption (27%) (19) , was set at 1 mg/d. The additional EAR for lactating women, which was determined by measurement of average zinc content in Japanese breast milk (1.83 mg/L) (29, 30) , average intake of breast milk in Japanese infants (0.78 L/d) (11, 
12), and extent of zinc absorption by lactating women (53%) (31) , was set at 3 mg/d. Because there is no remarkable difference between the zinc intake from breast milk of US and Japanese infants, the AI for Japanese infants aged 0 to 5 mo was set at 2 mg/d in accordance with the US/Canadian DRIs (19) . The AI for infants aged 6 to 11 mo was mean of the extrapolation of 2 mg/d using the 0.75th power of a weight ratio (2.6 mg/d) and the sum of zinc intake from complementary food and formula milk (3.1 mg/d) (32) .
Based on the results of a study in which subjects were administered 50 mg/d of zinc supplements (33) , the LOAEL of zinc was estimated to be 60 mg/d in women with a body weight of 61 kg. Based on this value and an uncertainty factor of 1.5, the UL for adults was set at 0.66 mg/kg/d. Since there are no available data, no ULs for infants, children, pregnancy and lactating women have been set. Table 2 summarizes the DRIs for zinc. The values are expressed as integral values in consideration of limitations in the accuracy of EAR calculation.
Copper
Background information
Copper functions as a component of several metalloenzymes, including monoamine oxidase, ferroxidase (ceruloplasmin), cytochrome c oxidase, and superoxide dismutase (CuSOD). Since ferroxidase is an essential enzyme in heme synthesis, copper deficiency induces normocytic, hypochromic anemia. Simple copper deficiency in human is rare, but has been observed in infants with a low copper intake (34) or patients receiving prolonged TPN (35) .
Determining DRIs
The EAR for copper in adults was determined using biomarkers of copper status. Biomarkers used were plasma copper, urinary copper, and salivary copper levels and plasma CuSOD activity. According to 2 reliable studies using a stable isotope (36, 37) , the minimal intake to achieve saturation of these biomarkers is estimated to be 0.72 mg/d. Because the mean body weight of the subjects in these studies was 74.7 kg, the 0.72 mg/d was set as the EAR for adults with a body weight of 74.7 kg. Thus, the EAR for each sex and age group of adults aged 18 y and older was determined by extrapolation of 0.72 mg/d using the 0.75th power of a weight ratio, and the EAR for children and adolescents aged 1 to 17 y by extrapolation of 0.72 mg/d using the 0.75th power of a weight ratio and a growth factor. Based on copper storage (13.7 mg) (38) and the extent of dietary copper absorption (60%) (39) in a full-term fetus, the additional EAR for pregnant women was determined to be 0.08 (13.74280 d40.6) mg/d. Based on the average copper concentration (0.35 mg/L) (40) and average volume of secretion (0.78 L/d) (11, 12) of breast milk in Japanese women and an estimated copper absorption rate of 60%, (39) the additional EAR for lactating women was determined to be 0.455 (0.3530.7840.6) mg/d, and the RDA set equal to 130% of the EAR. Based on the average copper concentration in breast milk in Japanese women (0.35 mg/L) (40) and the average intake of breast milk by Japanese infants (0.78 L/d) (11, 12) , the AI for infants aged 0 to 5 mo was determined to be 0.273 (0.3530.78) mg/d. Based on the average copper concentration in breast milk in Japanese women more than 6 mo after a delivery (0.16 mg/L) (40) , the average intake of breast milk (0.525 L/d) (41, 42) , and the average copper intake from complementary foods (0.195 mg/d) (32), the AI for infants aged 6 to 11 mo was determined to be 0.279 (43) and an uncertainty factor of 1.0, the UL for adults was set at 10 mg/d. Since there are no data available, ULs for children and adolescents have not been set. Table 3 summarizes the DRIs for copper.
Manganese
Background information
Since there are several manganese metalloenzymes, including arginase, pyruvate carboxylase and manganese superoxide dismutase, manganese is considered an essential nutrient. In a human study, 5 of 7 young men fed a low manganese diet (0.11 mg/d) for 39 d manifested a skin abnormality diagnosed as miliaria crystallina that was successfully treated by manganese repletion (1.53 to 2.55 mg/d) (44) . However, the possibility of dietary manganese deficiency is nearly 0% because plant foods, including cereals and beans, contain high levels of manganese.
Determining DRIs
Several manganese balance studies have been performed to estimate manganese requirements (45, 46) . However, the USA/Canada DRIs concluded that a minimal requirement to maintain manganese balance could not be estimated from a short-term balance study (47) . Accordingly, as there is insufficient information with which to set the EAR, the AI was set based on the average manganese intake of the Japanese population, which far exceeds the minimal requirement to maintain manganese balance. Based on a review of the manganese intake of the Japanese population, the average manganese intake of adults is estimated to be 3.7 mg/d (48) . To account for the differences in male and female energy intake, the AI for adults aged 18 y and older was set at 4.0 mg/d for men and 3.5 mg/d for women. The AI for children and adolescents aged 1 to 17 y was determined by extrapolation of the AI using the 0.75th power of a weight ratio and a growth factor. Based on the average manganese concentration in breast milk in Japanese women (0.011 mg/L) (40) and the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , the AI for infants aged 0 to 5 mo was set at 0.086 (0.01130.78) mg/d. Based on the average manganese concentration in breast milk in Japanese women, the average intake of breast milk (0.525 L/d) (41, 42) , and the average manganese intake from complementary foods (0.44 mg/d) (32), the AI for infants aged 6 to 11 mo was set at 0.45 (0.01130.52510.44) mg/d.
The AI for women who are not pregnant/lactating (3.5 mg/d) far exceeds the AI for pregnant women in the USA/Canada DRIs (2.0 mg/d) (47) . Accordingly, the AI for pregnant women was set at the same value as the AI for women who are not pregnant (3.5 mg/d). Based on the average manganese concentration in breast milk in Japanese women (0.011 mg/L) (40), the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , and the average extent of absorption of dietary manganese (about 5%) (49), manganese loss by lactation is estimated to be less than 0.3 (0.01130.7840.05) mg/d, which is much lower than the AI for women who are not pregnant/lactating (3.5 mg/d). Therefore, the AI for lactating women was set at the same value of the AI for women who are not pregnant/lactating.
Based on the manganese intake of vegetarians (47, 50) , the USA/Canada DRIs estimated the NOAEL of manganese to be 11 mg/d. Based on this value and an uncertainty factor of 1.0, the UL for manganese in 
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adults was set at 11 mg/d. Since there are no data available, ULs for children and adolescents have not been set. Table 4 summarizes the DRIs for manganese.
Iodine
Background information
Iodine is an essential component of thyroid hormone. As such, iodine deficiency induces mental retardation, hypothyroidism, goiter, cretinism, and varying degrees of other growth and development abnormalities.
Marine products contain iodine at high levels, in particular, kombu (a type of kelp) contains it at more than 2 mg/g dry weight. Since the Japanese routinely eat kombu, their average iodine intake is very much higher than that of other populations. Based on measurement of urinary iodine excretion (51, 52) , annual consumption of kombu (53) , and chemical iodine analysis of duplicate diets (54, 55) , the average iodine intake of the Japanese, which has been found to be intermittently high, is estimated to be 1.5 mg/d.
Determining DRIs
Similar to the USA/Canada DRIs (56), the EAR for iodine was determined by measurement of thyroid iodine accumulation and turnover. Based on the results of 2 USA studies (57, 58) , the average accumulation of radioiodine by the thyroid gland is estimated to be 93.9 mg/d in adults. Thus, the EAR for adults aged 18 y and older was set at 95 mg/d, and the RDA set equal to 140% of the EAR. The EAR for children and adolescents aged 1 to 17 y was determined by extrapolation of the EAR for adults aged 18 to 29 y using the 0.75th power of a weight ratio and a growth factor.
The iodine content of Japanese breast milk varies markedly with iodine intake (59). When a woman's iodine intake is less than 1.5 mg/d or her kombu ingestion is restricted, the average iodine content in her breast milk is estimated to be 133 mg/L (59, 60). Based on this average iodine concentration of breast milk and the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , the AI for infants aged 0 to 5 mo was set at 100 (13330.78) mg/d. The AI for infants aged 6 to 11 mo (130 mg/d) was determined by extrapolation of this value using the 0.75th power of a weight ratio.
Based on the median value of iodine turnover in newborn infants (75 mg/d) (61), the additional EAR for pregnant women was set at 75 mg/d. Based on the average iodine content in breast milk in Japanese women (133 mg/L) (59, 60) , the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , and the extent of absorption of dietary iodine (100%), the additional EAR for lactating women was determined to be 100 (13330.78) mg/d, and the RDA set equal to 140% of the EAR.
Initially, excessive iodine intake also induces hypothyroidism and goiter, a phenomenon referred to as the Wolff-Chaikoff effect. However, the Wolff-Chaikoff effect does not occur with continuous excessive iodine intake, a phenomenon referred to as "escape." Based on the results of an epidemiological study of subjects living in a coastal area of Hokkaido (62, 63) , which estimated the NOAEL of iodine for Japanese adults to be 3.3 mg/d, and an uncertainty factor of 1.5, the UL for iodine in adults was set at 2.2 mg/d. As this UL applies to continuous daily iodine intake, it is not necessary to restrict intermittent high iodine (up to about 5 mg/d) intake.
In a study of children aged 6 to 12 y, a significant increase in thyroid size was observed in subjects whose estimated iodine intake was more than 500 mg/d (64). Based on this observation, the UL for children aged 6 to 11 y was set at 500 mg/d. The UL for children aged 1 to 5 y was determined by extrapolation of the UL for children aged 6 to 7 y using a weight ratio. The UL for adolescents aged 12 to 14 y was set as the mean of 2 values: the value of the extrapolation of the UL for children aged 10 to 11 y using a weight ratio and the value of the extrapolation of the UL for adults aged 18 to 29 y using a weight ratio. The UL for adolescents aged 15 to 17 y was determined by extrapolation of the UL for adults aged 18 to 29 y using a weight ratio. Based on a case report of hypothyroidism in infants fed breast milk (60), the NOAEL of iodine for infants ages 0 through 5 mo is estimated to be 254 mg/d. Based on this value and an uncertainty factor of 1.0, the UL for infants aged 0 to 5 mo was set at 250 mg/d. Since the UL is 250 mg/d for both infants aged 0 through 5 mo and children aged 1 to 2 y, the UL for infants aged 6 to 11 mo was also set at 250 mg/d.
Excessive ingestion of iodine by pregnant or lactating women can cause hypothyroidism in their infants. In a case report of hypothyroidism in infants fed breast milk (60), the mothers' iodine intake from kombu was estimated to be 2.28 to 3.18 mg/d. If the iodine intake from foods other than kombu is taken into consideration, their total iodine intake would exceed the UL for women who are not pregnant. Accordingly, the UL for women who are not pregnant can be applied to pregnant and lactating women. Table 5 summarizes the DRIs for iodine.
Selenium
Background information
Selenium functions as a form of selenocysteine residue in protein. Genome analysis has identified 25 selenium-containing proteins in humans, including glutathione peroxidase (GPX), iodothyronine deiodinase, and thioredoxin reductase. Keshan disease, an endemic form of fatal cardiomyopathy that has been observed in children living in a low-selenium area of China, has been firmly linked to selenium deficiency, with administration of selenium having been found to prevent it (65). Several clinical selenium-responsive syndromes have been observed in patients receiving prolonged TPN, among whom one patient with an extremely low plasma selenium concentration (9 ng/mL) developed muscle pain and tenderness in the thighs, resulting in an inability to walk (66) , while another developed a cardiomyopathy and died after a cardiac arrest secondary to septic shock (67) .
Determining DRIs
Synthesis of selenium-containing protein is strongly associated with selenium intake. The relationship between selenium intake and plasma GPX activity has been particularly well established. In the USA/Canada DRIs, the EAR for selenium was set based on determination of the minimal intake resulting in saturation in plasma GPX activity (45 mg/d for adults with a body weight of 76 kg) (68) . However, the WHO concluded that selenium deficiency is prevented when 2/3 of the value of saturated plasma GPX activity is maintained (69) . Based on the results of a Chinese study (70) , the selenium intake necessary to maintain 2/3 of the value of saturated plasma GPX activity is estimated to be 24.2 mg/d for adults with a body weight of 60 kg. Accordingly, the EAR for selenium in adults aged 18 y and older was calculated by extrapolation of this value using the 0.75th power of a weight ratio. The EAR for children and adolescents aged 1 to 17 y was calculated by extrapolation of this value using the 0.75th power of a weight ratio and a growth factor. 
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Based on average body selenium concentration (250 mg/kg) (71) and the sum of placenta and birth weight (3.5 kg), fetal and placental selenium storage is estimated to be approximately 900 mg (25033.5) during pregnancy. Based on average blood selenium concentration (184 mg/L), the increased selenium requirement due to increase in blood volume (1.5 L) during pregnancy is estimated to be approximately 300 mg (72) . Because absorption of dietary selenium is estimated to be about 90% (73) , the additional EAR for pregnancy is estimated to be 4.8 ((9001300)4280 d40.9) mg/d, and the RDA set equal to 120% of the EAR. Based on the average selenium content in the breast milk of Japanese women (17 mg/L) (40), the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , and the extent of absorption of dietary selenium (90%) (73) , the additional EAR for lactating women was set at 15 (1730.7840.9) mg/d, and the RDA set equal to 120% of the EAR.
Based on the average selenium concentration in the milk of Japanese women (17 mg/L) (40) and the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , the AI for infants aged 0 to 5 mo was set at 13.3 (1730.78) mg/d. The AI for infants aged 6 to 11 mo was determined by extrapolation of 13.3 mg/d using the 0.75th power of a weight ratio.
Based on a Chinese report of chronic selenium intoxication, the NOAEL of selenium is estimated to be 13.3 mg/kg/d (74) . However, an epidemiological study found that long-term supplementation of 200 mg/d of selenium increased the incidence of Type 2 diabetes in subjects with sufficient selenium intake (75) , indicating that supplementation at this level causes adverse effects if intake through other sources is adequate. The average selenium intake of the Japanese population is estimated to be approximately 100 mg/d (76), which far exceeds the RDA of selenium. Thus, the UL of selenium was set at 300 (1001200) mg/d for men aged 30 to 49 y, whose mean body weight (68.5 kg) is the highest among the sex and age groups. The ULs for other sex and age groups, including children and adolescents, were determined by extrapolation of 300 mg/d using a weight ratio. Table 6 summarizes the DRIs for selenium.
Chromium
Background information
Trivalent chromium is believed to enhance the action of insulin in the form of a chromium-binding oligopeptide. Patients receiving prolonged TPN without chromium supplementation have been observed to experience glucose intolerance together with several symptoms and disorders, including weight loss, peripheral neuropathy, and low respiratory quotient (77) . Since these symptoms disappear with administration of trivalent chromium, their origin has been attributed to chromium deficiency.
Determining DRIs
As there is currently no means of determining the metabolic balance of chromium in adults, the USA/ Canada DRIs set the AI for chromium based on a chromium intake study (78) . Because no study has investigated chromium intake in Japan, the EAR was tentatively based on the results of a balance test of chromium in the elderly (79) , in which a positive balance was observed in subjects whose average chromium intake was 12.8 mg/1,000 kcal. Accordingly, the EAR for adults aged 18 y and older was determined based on the an average chromium intake of 12.8 mg/1,000 kcal and the estimated energy requirement for physical activity level II, and the RDA for chromium set equal to 120% of the EAR. The EAR for children and adolescents aged 1 to 17 y has not been set due to the tentative nature of the adult EAR, nor has the EAR for either pregnant women or lactating women, the former due to lack of data and the latter due to an inability to measure absorption of dietary chromium. Based on the median chromium concentration in milk in Japanese women (1.0 mg/L) (80) and the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , the AI for infants aged 0 to 5 mo was set at 0.78 mg/d. The AI for infants aged 6 to 11 mo was determined by extrapolation of 0.78 mg/d using the 0.75th power of a weight ratio.
The UL for chromium has not been set because the quantitative relationship between trivalent chromium intake and the possible adverse effects of excessive trivalent chromium intake has been insufficiently established. Table 7 summarizes the DRIs for chromium.
Molybdenum
Background information
Molybdenum functions as a cofactor for a limited number of enzymes, including xanthine oxidase, aldehyde oxidase, and sulfite oxidase in mammals, and is believed to be an essential trace element in animal nutrition. Human nutritional deficiency of molybdenum was observed in a patient subjected to prolonged TPN (81), who manifested clinical symptoms suggestive of sulfite oxidase deficiency. Other symptoms, including irritability, leading to coma, tachycardia, tachypnea, and night blindness, have been reported.
Determining DRIs
The EAR for molybdenum was based on the results of a human balance test of 4 American male subjects (mean body weight, 76.4 kg), all of whom showed a positive balance and no manifestation of any disorder when they ingested 22 mg/d of molybdenum for 102 d (82) . Based on estimation of integumental and sweat molybdenum loss (3 mg/d) (83), the EAR for adults with a body weight of 76.4 kg was calculated to be 25 mg/d. The EAR for adults aged 18 y and older was calculated by extrapolation of 25 mg/d using the 0.75th power of a weight ratio. Since the EAR for adults is based on 1 study of only 4 subjects, the EAR for children and adolescents aged 1 to 17 y has not been set, nor has the additional EAR for pregnant women due to lack of data. Based on the average molybdenum content of the milk of Japanese women (3 mg/L) (80, 84) , the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , and the extent of absorption of dietary molybdenum (93%) (85) , the additional EAR for lactating women was set at 3 mg/d (330.7840.93), and the RDA for molybdenum set equal to 120% of the EAR.
Based on the average molybdenum content of the milk of Japanese women (3 mg/L) (80, 84) and the average intake of breast milk in Japanese infants (0.78 L/d) (11, 12) , the AI for infants aged 0 to 5 mo was set at 3 (330.78) mg/d. The AI for infants aged 6 to 11 mo was determined by extrapolation of 2.34 mg/d using the 0.75th power of a weight ratio.
Due to the lack of data regarding the dose-dependent adverse effects of excessive molybdenum intake in humans, the UL for molybdenum is based on the NOAEL of molybdenum for rats (900 mg/kg/d) (86) . Based on the NOAEL and an uncertainty factor of 100, the UL for adults aged 18 y and older was set at 9 mg/kg/d. Due to lack of data, ULs for children and adolescents have not been set. Table 8 summarizes the DRIs for molybdenum. --2  ---2  -6-11 mo  --3  ---3  -1-2 y  --------3-5 y  --------6-7 y  --------8-9 y  -------- 
